Yale researchers find possible new route for cancer treatment

New Haven, Conn.-based Yale researchers found removing extra chromosomes from cancer cells inhibits tumor formation and could be a new route for cancer treatment.

The study, published July 6 in Science, used CRISPR Targeting to target extra chromosomes, known as aneuploidy, in melanoma, gastric cancer and ovarian cell lines. Researchers removed a long portion of chromosome 1, which is found in several cancers and linked to disease progression.

The study found aneuploidies play a role in cancer development and eliminating them stunts growth potential. Aneuploidy also causes "collateral therapeutic vulnerabilities that can be targeted to selectively eliminate cells with chromosome dosage imbalances," researchers wrote.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars